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Abstract
The use of graphene nanomaterials (GNMs) for biomedical applications targeted to the central nervous system is exponentially increasing, although precise information on their effects on brain cells is lacking. In this work, we addressed the molecular changes induced in cortical astrocytes by few-layer graphene (FLG) and graphene oxide (GO) flakes. Our results show that exposure to FLG/GO does not affect cell viability or proliferation. However, proteomic and lipidomic analyses unveiled alterations in several cellular processes, including intracellular Ca 2+ ([Ca 2+ ]i) homeostasis and cholesterol metabolism, which were particularly intense in cells exposed to GO. Indeed, GO exposure impaired spontaneous and evoked astrocyte [Ca 2+ ]i signals and induced a marked increase in membrane cholesterol levels.
Importantly, cholesterol depletion fully rescued [Ca 2+ ]i dynamics in GO-treated cells, indicating a causal relationship between these GO-mediated effects. Our results indicate that exposure to GNMs alters intracellular signaling in astrocytes and may impact on astrocyteneuron interactions.
Introduction
Because of their unique physical and chemical properties, graphene nanomaterials (GNMs)
are currently exploited for a range of applications in tissue engineering, regenerative medicine and drug/gene delivery to the central nervous system (CNS). [1, 2] The implementation of strategies that make use of GNMs for neurological applications, however, requires a detailed knowledge of the impact of such materials on the biology of the various CNS cell populations.
The impact of GNMs on the morphological and functional properties of primary neurons has been extensively described. [3] [4] [5] [6] Conversely, a detailed description of the biological interactions between GNMs and glial cells has not been fully addressed yet.
Amongst the various glial subtypes populating the CNS, astrocytes represent 20-40 % of cells. [7] Astrocytes actively contribute to the activity of neural circuits by controlling the dynamics of the perineuronal milieu through their capacity to maintain the extracellular ion and neurotransmitter homeostasis. [8, 9] Moreover, astrocytes are involved in the structural remodeling of neural networks by directing synapse formation and pruning, regulating brain metabolism and participating in the neurovascular coupling. [10, 11] Many of these functions are mediated by dynamic variations in intracellular calcium levels ([Ca 2+ ]i), which follow the paracrine activation of metabotropic receptors by signaling molecules released from cells of neuronal, glial and vascular origin. [12] Of note, alterations of astroglial [Ca 2+ ]i dynamics are observed under several central nervous system diseases; however, whether this dysregulation plays a pathogenic role or reflects reparative processes following brain damage is still unclear. [10, [13] [14] [15] [16] [17] These diverse roles can be fulfilled because of the ability of astrocytes to respond to a large variety of environmental cues through alterations of their molecular and functional properties. [18] [19] [20] Whether astroglial plasticity can be influenced by exposure to various nanomaterials remains to be established.
A limited number of studies have described the specific effects induced by G-related materials (GRMs) on astrocytes. Single-walled carbon nanotubes (SWCNTs) administered as dispersions, strongly affected the viability of chicken-derived glial cell cultures. On the contrary, functionalized water-soluble SWCNTs induced stellation of mouse cortical astrocytes and increased GFAP expression, in the absence of sizeable effects on cell viability. [21] PEG-SWCNT films had differential effects on astrocytes, with thinner films inducing stellation, and thicker films promoting de-differentiation with cell enlargement, reduced GFAP expression and increased proliferation. [22, 23] Graphene oxide (GO) did not affect astrocyte viability in vitro. [5, 24] We have recently shown that GO impacts on astrocyte homeostatic functions by affecting their ability to buffer extracellular K + and glutamate, with repercussions on the excitability of co-cultured neurons. [24] Although, the cellular and molecular mechanisms underlying the graphene-mediated changes in the astroglial phenotype remain to be identified, injection of reduced GO flakes in the rodent hippocampus did not induce reactive astrogliosis, indicating that GNMs are well tolerated also in vivo. [25] In this work, we studied the effects of long-term exposure of primary cortical astrocytes to few-layer graphene (FLG) and GO on their proteomic and lipidomic profiles. The analysis identified profound alterations in the intracellular protein networks that control Ca 2+ signaling, accompanied by a marked increase in cell cholesterol that was causally related to Ca 2+ dysregulation. The effects of GNMs on astrocyte signaling and activation may impact on the functional astrocyte-neuron interactions.
Results

Production and characterization of FLG / GO flakes
The GRMs used in the present study were FLG and GO flakes. FLG was prepared by exfoliation of graphite through interaction with melamine by ball-milling treatment. [26] After exfoliation, melamine was removed to obtain stable dispersions of FLG in H2O. GO, provided by the Grupo Antolin Ingeniería (Burgos, Spain), was obtained by oxidation of carbon fibers (GANF Helical-Ribbon Carbon Nanofibres, GANF ® ). Initial GO suspensions were washed with H2O to remove the presence of acids and were fully characterized. Transmission electron microscopy (TEM) analysis revealed a similar lateral size distribution of FLG and GO, showing high polydispersity of the solutions ranging from 100 to 1,500 nm (Figure 1a-c) . In both FLG and GO, Raman spectroscopy displayed the two main features of G-based materials: the so-called D and G peaks corresponding to disordered carbon and to the sp 2 tangential mode, respectively. [27] The D band appeared at 1347 cm -1 and the G peak arose at ~1,576 cm ) was observed in the FLG structure, while the GO spectrum instead displayed a bump. Accordingly, elemental analysis gave very different results between the two GNMs, as displayed in Figure 1e , with an amount of oxygen around 5% (w/w) in FLG and 49% in GO. Finally, thermo-gravimetric analysis (TGA) was used to quantify the degree of functionalization of FLG and GO (Figure 1f ). In agreement with
Raman and elemental analyses, the weight loss observed in FLG at 600 ºC was only 8.5%, confirming the low quantity of oxygen groups generated by the exfoliation process in comparison to GO, whose TGA displayed a weight loss of 49.2%. 
FLG and GO do not affect astrocyte viability and cell cycle and proliferation
Primary astrocytes were exposed to FLG/GO (1 and 10 µg/ml) or to the corresponding vehicle solution (0.046 ppm melamine/H2O for FLG or H2O for GO) for up to 7 days, and cell viability was investigated at various time points by flow cytometry by using propidium iodide (PI) and AlexaFluor488-conjugated Annexin V to detect early and late apoptotic cells, respectively. As a positive control, cells were treated with the strong inducer of apoptosis staurosporine (POS; 1 µM) (Figure 2a-c) . Cell viability was also assessed after a 2-day exposure of confluent cultures of mature astrocytes to FLG/GO (Figure 2d ). Exposure to either FLG or GO did not induce cell death at any of the tested concentrations and exposure times. Since no dose-dependent effects were observed on cell viability, all subsequent experiments were performed using the highest GNM concentration (10 µg/ml).
We subsequently evaluated cell division and cell cycle upon exposure to FLG/GO.
The cell number in untreated and FLG/GO-treated samples showed comparable changes over time, suggesting a negligible effect of the material on astrocyte division (Figure 2e ). In accordance with these data, flow-cytometry analysis showed that FLG/GO treatment did not affect the percentage of cells in the various cell cycle phases (Figure 2f,g ).
We next evaluated whether exposure to GNMs led to astrogliosis (Figure 2h-k) . To this end, astrocyte cultures were immunostained with antibodies to the intermediate filament glial fibrillary acidic protein (GFAP; Figure 2h ), a classical marker of reactive gliosis. [28, 29] The levels of GFAP were not altered by the exposure to FLG/GO, as shown from both immunostaining (Figure 2h ,i) and western blot (Figure 2j,k) analysis.
These results indicate that exposure to FLG and GO does not affect astrocyte proliferation, survival and reactivity. produced by astrocytes in the brain, 31 were markedly upregulated by GO (Figure 4d ).
Cholesterol plays a crucial role in astrocyte physiology, as it rapidly re-distributes in the cell membrane in response to a variety of stimuli, [32] [33] [34] and is linked to lipid raft assembly and Ca 2+ signaling. [35] To get more insights into the mechanisms underlying the variations of cholesterol levels induced by GO, we stained primary astrocytes with the cholesterol-specific fluorescent marker filipin. In agreement with the lipidomics results, GO-exposed astrocytes displayed strongly increased cholesterol levels with respect to vehicle-treated cells, while FLG induced only a small increase in filipin staining (Figure 4e ).
Highly concentrated cholesterol in the plasma membrane is a feature of lipid rafts, membrane microdomains characterized by clusters of lipids and a variety of signaling and scaffolding proteins, including ion channels. [36] We evaluated whether FLG/GO exposure affected raft distribution and organization by live labeling GNM-treated and control astrocytes with the fluorescently labeled cholera toxin B-subunit (Vybrant) that recognizes the GM1 ganglioside, a specific marker of membrane rafts (Figure 4f 
Exposure to GO inhibits intracellular Ca 2+ signaling
As described above, treatment with GO specifically perturbed the cellular pathways involved To unravel the mechanisms underlying the observed effects, we asked whether GO alters the release of Ca 2+ from intracellular stores and/or the influx of Ca 2+ through the plasma membrane. [37] To address this issue, we exposed GO-treated astrocytes to thapsigargin in Ca 2+ -free extracellular saline to deplete intracellular Ca 2+ stores (Figure 5c ). [38] 
Conclusion and Discussion
It is well known that astrocytes in vivo respond to pathological insults through complex molecular and functional changes that modify their homeostatic properties and alter the structural and functional integrity of the neuronal tissue. [42] These dynamic changes define astrocyte reactivity and can be detrimental or beneficial according to the pathological settings.
The upregulation of GFAP expression has been considered a marker of astrocyte reactivity and a landmark of various pathological conditions such as CNS insults, ischemia and several neurodegenerative diseases. [43] Although cultured astrocytes avidly uptake GNMs through the endo-lysosomal pathway, [24] here we show that exposure to GNMs does not affect astrocyte viability and does not cause any significant alteration in cell cycle progression. In addition, the expression of GFAP is unaltered, indicating that, at least in vitro, exposure of cortical astrocytes to GNMs does not trigger reactive astrogliosis.
The physico-chemical properties of GNMs are dictated by their size, shape and chemistry, which in turn determine the biological effects they cause upon interaction with living organisms. [44] Our study shows that exposure to GNMs profoundly affects the proteome of cultured astrocytes. While over 300 proteins showed appreciable changes upon GO treatment, only 100 were altered by FLG, and remarkably, only 21 proteins were common to the two materials. This supports the notion that the distinct features of FGL and GO flakes strongly influence their interaction with cultured cells, triggering the activation of distinct, almost non-overlapping pathways. The common processes affected by both FLG and GO include cytoskeleton remodeling and lipid binding proteins. The observed alteration of cytoskeletal proteins is in line with the marked shape change displayed by GNM-treated astrocytes, which acquire a highly elongated morphology reminiscent of activated cells. [24] The impact of GNMs on lipid binding proteins is of interest, as it correlates with the wide array of lipid species that are up-or downregulated in GNM-exposed cells, particularly cholesterol.
The lipidomic screen revealed that phospholipid, cholesterol and triglyceride metabolism is significantly altered following exposure of astrocytes to GO and FLG. PCs, the most abundant structural phospholipids playing a crucial role in the modulation of membrane fluidity, [45] are up-regulated by GO and down-regulated by FLG, while TGs, the main storage form of lipid precursors, [45] show an opposite modulation. Interestingly, cholesteryl esters and free cholesterol, fundamental lipids produced by astrocytes in the brain, [31, 46] are markedly upregulated by GO. Brain cholesterol is mainly synthetized in situ, since dietary supply is fenced off by the blood-brain barrier. In the adult brain, most of cholesterol is produced by astrocytes in support to the metabolic needs of neurons. [31, 46] Thus, the observed increase in cholesterol, in addition to cell-autonomous effects on astrocytes, may impact on the metabolic and electrical activity of co-cultured neurons. Interestingly, and in line with our findings, increased membrane cholesterol levels have been recently reported in primary neurons and cell lines grown onto to graphene substrates. Remarkably, cholesterol was the principal mediator of the cellular and physiological alterations induced by graphene on the overlying cell cultures. [47] Amongst the pathways specifically altered by GO, a prominent role is played ]i signaling has been reported in astrocytes during aging. [50, 51] By contrast, pathological elevation of both spontaneous and evoked [Ca 2+ ]i responses in astrocytes have been described in a mouse model of Alzheimer's disease. [52] In focal ischemia, the spreading of cell death from the ischemic core to adjacent areas is mediated by [Ca 2+ ]i waves triggered by the massive release of ATP and activation of P2Y purinergic receptors. [15, 53] More recent data have shown that enhanced astrocytic [Ca 2+ ]i responses actively contribute to some forms of epilepsy. [54, 55] Based on this evidence, the demonstration that GO depresses [Ca 2+ ]i dynamics in primary astrocytes corroborates the view that this material could affect CNS functions in vivo also through changes in astrocyteastrocyte and astrocyte-neuron signaling.
The efficacy of Ca 2+ signaling in astrocytes relies on the efficient replenishment of the ER store through store-operated Ca 2+ entry (SOCE). This process is mediated by the dynamic interactions between the ER protein STIM and the plasma membrane protein ORAI that predominantly occur at membrane rafts. [56] [57] [58] Cholesterol-rich membrane rafts are essential for the efficient propagation of Ca 2+ transients, as they assemble the required repertoire of Ca 2+ channels and receptors to sense external stimuli and translate them into the activation of appropriate intracellular signaling cascades. [59] Recently, a cholesterol-binding domain was identified in STIM1. The binding of STIM1 to cholesterol prevents the interaction with ORAI, and consequently inhibits Ca 2+ influx from the extracellular environment into the cell. [60] In line with this evidence, our results indicate that cholesterol depletion is sufficient to rescue Collectively, our current and previously published results [6, 24] support the view that GO is an exploitable material for biomedical applications in neuromedicine, since it is not harmful to neurons and astrocytes and regulates important astrocyte homeostatic functions. However, since GO affects the balance between excitatory and inhibitory signaling in neuronal networks [6] and modulates [Ca 2+ ]i dynamics in primary astrocytes through changes in cholesterol levels, its applicability as functional substrate for prosthetic devices remains to be unequivocally determined. In this context, future studies will address whether the GO-induced effects described here are relevant for the proper functionality of the astrocyte syncytium and neuron-astrocyte communication in vivo.
Experimental Section
Synthesis and characterization of pristine graphene and graphene oxide
Few-layer graphene (FLG) flakes were prepared by exfoliation of graphite through interaction with melamine by ball-milling treatment. [61] Elemental analysis revealed that FLG contained 0.46% (w/w) melamine, corresponding to 0.046 ppm for a 10 µg/ml FLG suspension.
Graphene oxide (GO) was provided by Grupo Antolin Ingeniería (Burgos, Spain) by oxidation of carbon fibers (GANF Helical-Ribbon Carbon Nanofibres, GANF ® ) and sodium nitrate in sulfuric acid at 0 °C. For a detailed description of FLG and GO synthesis and physical-chemical characterization, please refer to (Leon et al., 2016 ) [26] and (Bramini et al., 2016 ) [6] .
Preparation of primary astrocytes
All experiments were carried out in accordance with the guidelines established by the 
Cell viability assay and cell cycle analysis
Primary astrocytes were exposed to FLG or GO (1 and 10 µg/ml), or to equivalent volumes of the respective vehicle (0.046 ppm melamine/H2O for FLG or H2O for GO) for 24 h, 72 h and . Gene ontology and pathway analysis was performed using DAVID Bioinformatics Resources (v 6.8). We used DAVID default population (Rattus norvegicus) background in enrichment calculation. [62, 63] Heat maps were generated using the MeV TM4 software V 4.9 (http://www.tm4.org). The UNIPROT database (http://www.uniprot.org/) was used to perform manual annotation of biological functions of proteins.
Sample preparation. For all the "omics" studies, primary astrocytes were plated in 60 mm
Petri dishes pre-coated with 0.01 mg/ml PDL at a density of 1x10 6 cell/dish, then incubated for 72 h with either 10 µg/ml of FLG or GO and the respective control solutions (see above).
Five biological replicates of primary astrocyte cultures from two independent preparations (individual rats) were prepared and used for both proteomics and lipidomics analysis.
Untargeted Lipidomics
Sample preparation. At the end of the incubation (72 h) cells were scraped, washed with PBS and immediately transferred into 1.5 ml Eppendorf tubes. Cell lipid content was then extracted using a Bligh-Dyer protocol. [64] In brief, 2 ml of 1:2 chloroform/methanol mixture (v/v) was added to the vials and vortexed for 30 s. Chloroform (0.5 ml) and water (0.5 ml)
were then sequentially added and thoroughly mixed after each addition. The samples were then centrifuged for 15 min at 3,500 g at RT. At the end of the process, the organic (lower) phase (~1.5 ml) was transferred to glass vials. The aqueous phases were re-extracted to increase the overall recovery. The organic phases from both extractions were pooled in a glass vial and dried under a nitrogen stream. The extracted lipids were re-dissolved in 0.1 ml of a 9:1 methanol: chloroform solution and analyzed by liquid chromatography coupled to highresolution mass spectrometry.
Data acquisition. Untargeted lipidomics of astrocyte lipid extracts was performed on a UPLC
Acquity system coupled to a Synapt G2 QToF high-resolution mass spectrometer. Lipids were separated on a CSH C18 column (1. Principal Component Analysis (PCA) [65] was performed. The peak areas of the observed features were normalized by the total ion current and Pareto-scaled prior to PCA. Scores plots were used to visualize differences between challenging GNMs and their corresponding vehicles for each biological replicate. XCMSonline [66] was used for univariate lipidomic data analysis. All LC-MS raw data files were converted to the .netCDF format using the waters DataBridge software. The files were then uploaded to XCMSOnline and processed as a pair group experiment using the default UPLC-High Res POS parameters. Briefly, the centWave method was used for feature detection (m/z tolerance = 15 ppm, min peak width = 2 s, max peak width = 25 s). The obiwarp method was used for retention time correction (profStep = 0.5) and chromatograms were aligned using the following parameters: mzwid 0.01, minfrac 0.5, bw = 2. A data matrix reporting the observed accurate mass and retention times (tR) for all the features was generated and converted into an excel file. Univariate statistical analysis was then performed using a two-tailed unpaired Student's t-test between GNMs and the corresponding vehicle groups using Microsoft Excel. Following this procedure, only the features present in both rats were retained. Only the most significant features, showing p < 0.05 and an absolute fold change of at least 20% in the comparison were used for further annotation.
Lipid identification. Lipid identification was performed by interrogating the web-based algorithms METLIN [67] and LIPIDMAPS [68] Putative IDs were finally verified using class-specific retention time and tandem mass analysis. [69] Untargeted Proteomics Sample preparation. At the end of the 72 h incubation, cells from the four groups (incubated with GO, FLG, and respective controls) were scraped and washed with PBS to remove serum, then lysed by MilliQ water addition. Following the BCA protein assay, 50 µg of proteins were collected from all the samples and transferred to Eppendorf tubes. Samples were then isotopically labeled using the TMT sixplex kit, [30] 
LC-MS/MS analysis.
The tryptic peptide mixture was analyzed using a Synapt G2 QToF instrument equipped with a nanoACQUITY liquid chromatographer and a nanoSpray ion source. Peptides were separated on a BEH nanobore column (75 micron ID x 25 cm length) using a linear gradient of ACN in water from 3 to 55% in 2 h, followed by a washout step at 90% ACN (10 min) and a reconditioning step to 3% for 20 min. Flow rate was set to 300 nl/min. Spray voltage was set to 1.6 kV, cone voltage was set to 28 V, spray gas was set to 0. Data analysis. The acquired raw data files were processed using the PLGS software to recalibrate the mass spectra and generate the precursor-fragments peaklist. Protein identification and quantification was performed by interrogating the SwissProt database using the MASCOT Server software. [70] The search parameters were set as follows: quantification:
TMT6plex; fixed modifications: carbamidomethyl (C), TMT6plex (N-term), TMT6plex (K); 
RNA Preparation and Real-Time PCR Analysis
Total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions, purified using RNeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany), and reverse transcribed into cDNA using the SuperScript IV First-Strand Synthesis System (Invitrogen). Gene expression was measured by quantitative real time PCR using the CFX96 Touch Real-Time PCR Detection System (Biorad). Relative gene expression was determined using the 2-DDCT method. Gusb and Hprt1 were used as reference genes. The list of primers used is provided in Table S1 .
Calcium Imaging
Cultures were loaded for 30 min at 37 °C with 1 µg/ml cell-permeable Fura-2 AM (#F1221, ThermoFisher) in the culture medium. Cells were then washed in recording buffer (140 NaCl, 
Statistical Analysis
Data are expressed as means ± sem throughout. Normal distribution was assessed using D'Agostino-Pearson's normality test. In case of two experimental groups, data were analyzed using the Student's t-test or the Mann-Whitney's U-test. When more than 2 experimental groups with normally distributed data were involved, one-way or two-ways ANOVA was used, followed by the Bonferroni's multiple comparison test. Significance level was preset to p<0.05. Statistical analysis was carried out using the Prism6 software (GraphPad Software, Inc.).
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author. Figure S1 . mRNA levels of Ca 2+ and integrin binding family member 2 (Cib2), calreticulin (Calr), calpastatin (Cast) and calcineurin binding protein 1 (Cabin1) were quantified by qRT-PCR in primary astrocytes treated with FLG or GO at 10 µg/ml for 72 h. Gusb and Hprt1 were used as reference genes. *p<0.05, **p<0.01; one-way ANOVA/Bonferroni's tests; n=6. Data are expressed as mean ± sem 
